On Tuesday, USA Compression Partners earned a positive adjustment to its Relative Strength (RS) Rating, from 69 to 77.
IBD's proprietary RS Rating tracks market leadership by using a 1 (worst) to 99 (best) score that identifies how a stock's price action over the last 52 weeks compares to other publicly traded companies.
Decades of market research shows that the best stocks often have an 80 or better RS Rating in the early stages of their moves. See if USA Compression Partners can continue to show renewed price strength and hit that benchmark.
When To Sell Stocks To Lock In Profits And Minimize Losses
USA Compression Partners is building a consolidation with a 30.10 buy point. See if it can break out in volume at least 40% higher than normal.
Earnings growth increased last quarter from 44% to 800%. But revenue gains fell from 11% to 9%. The company is expected to report its latest earnings and sales numbers on or around May 6.
USA Compression Partners holds the No. 3 rank among its peers in the Oil & Gas-Field Services industry group. NCS Multistage is the top-ranked stock within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
Stocks With Rising Relative Strength Ratings
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
